RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...
jkj, thanks for the laugh... one of the more common threads in failed trials is the "control group performed better than expected" which is a run for hills blah, blah...why the control group is what it is and what it was before and what it will be in the future it doesn't perform better, what it is that the trial design failed by over/under estimating how the control group behaves...i have seen this silliness in many failed trials, i can't remember seeing it referenced in successful trials..PS IMO that is a big risk in the supposed upcoming BoM trial...and FYI this failure is IMO likely due to small PI and PII trials that are not properly controled or powered or designed or and really a problem if previous trials are single arm, etc. it is the selection bias problem